Selective autophagy ensures the removal of specific soluble proteins, protein aggregates, damaged mitochondria, and invasive bacteria from cells. Defective autophagy has been directly linked to metabolic disorders. However how selective autophagy regulates metabolism remains largely uncharacterized. Here we show that a deficiency in selective autophagy is associated with suppression of lipid oxidation. Hepatic loss of Atg7 or Atg5 significantly impairs the production of ketone bodies upon fasting, due to decreased expression of enzymes involved in β-oxidation following suppression of transactivation by PPARα. Mechanistically, nuclear receptor co-repressor 1 (NCoR1), which interacts with PPARα to suppress its transactivation, binds to the autophagosomal GABARAP family proteins and is degraded by autophagy. Consequently, loss of autophagy causes accumulation of NCoR1, suppressing PPARα activity and resulting in impaired lipid oxidation. These results suggest that autophagy contributes to PPARα activation upon fasting by promoting degradation of NCoR1 and thus regulates β-oxidation and ketone bodies production.
A utophagy is an intracellular protein degradation pathway mediated by lysosomes. Among several known autophagic pathways, the best understood is macroautophagy (hereafter referred to as autophagy), which is characterized by formation of a double-membrane structure called the autophagosome that fuses with the lysosome. The lysosome contains various hydrolases, including proteases, lipases, glycosidases, and nucleases; therefore, autophagy can degrade multiple types of cytoplasmic components simultaneously and provide the resultant molecular building blocks, such as amino acids, glucose, nucleotides, and fatty acids, for use by starving cells 1 . Experiments in mouse models have shown that autophagy is required to maintain the levels of amino acids and glucose in blood and tissues of neonatal and adult mice during fasting [2] [3] [4] [5] [6] . Therefore, in order to adapt to fasting, mice require the supply of nutrient molecules provided by autophagic degradation.
Upon fasting, cells shift their metabolism from glucose metabolism to fatty-acid oxidation to produce energy 7, 8 . For fatty-acid oxidation to occur, triglycerides stored in the cell as lipid droplets must be degraded to fatty acids in the cytosol and/or lysosomes. Hydrolysis of triglycerides by cytoplasmic neutral lipases, such as adipose triglyceride lipase, hormone sensitive lipase, and carboxylesterases, are the major mechanisms for mobilizing triglycerides into fatty acids 8, 9 . Lysosomes are also involved in hydrolysis of triglycerides. In fact, ablation of lysosomal acid lipase in mice results in massive triglyceride and cholesterol storage in the liver 10 . Selective autophagic degradation of lipid droplets in lysosomes (termed lipophagy) is thought to contribute to mobilization of triglycerides during starvation 11 . Supply of lipids through canonical autophagy, but not lipophagy, is also required to replenish triglycerides in lipid droplets, which are the source of molecules for fatty-acid oxidation 12 .
Since the discovery of lipophagy in mammals, many studies have shown that autophagy is involved in lipid metabolism, including lipogenesis, lipolysis, fatty-acid oxidation, ketogenesis, and cholesterol efflux 13 , and that loss of autophagy in the liver obstructs the mobilization of triglycerides into fatty acids, resulting in steatosis and an insulin-resistant state 11, 14 . The physiological importance of lipophagy has been described in neurons, macrophages, cancer cells, and enterocytes [15] [16] [17] [18] . Recently, however, conflicting results regarding lipophagy have been reported. First, although the accumulation of lipid droplets in autophagy-deficient mouse livers is believed to constitute conclusive evidence of lipophagy, several independent analyses of knockout mice lacking autophagic components specifically in hepatocytes have observed a reduction in the number of lipid droplets [19] [20] [21] [22] [23] . Second, the autophagy machinery participates in lipid droplet formation in hepatocytes and cardiomyocytes 22, 24 , and deletion of autophagy-related genes in mouse liver decreases the level of triglycerides 22 and impairs ketogenesis 23 . Third, suppression of autophagy represses the activity of the nuclear receptor, liver X receptor α (LXRα), which has a vital role in fattyacid synthesis, and prevents liver steatosis under physiological fasting and high-fat diet conditions 21 . Therefore, it is plausible that the role of autophagy in lipid metabolism is beyond the scope of simple degradation of lipid droplets and membranes, implying that lipid metabolism is regulated by autophagy in an as-yetuncharacterized way.
Autophagy can regulate transactivation of a transcription factor through selective turnover of its corresponding regulator. Nuclear factor erythroid 2-related factor 2 (Nrf2) induces a battery of genes encoding anti-oxidant proteins and proteins related to proteostasis, such as proteasome subunits and autophagyrelated proteins. p62/SQSTM1 (henceforth p62) interacts with the autophagosome-localizing protein LC3 through its LC3interacting region (LIR) and is degraded by autophagy [25] [26] [27] .
p62 also binds to Kelch-like ECH-associated protein 1 (Keap1), an adaptor protein of the Cullin-3-based ubiquitin ligase for Nrf2, and inhibits its E3 activity 28, 29 . Thus, quantitative regulation of p62 via autophagy determines Nrf2 activity. In fact, loss of autophagy in mouse liver is accompanied by persistent activation of Nrf2 due to prominent accumulation of p62, leading to liver enlargement, severe liver injury, and benign liver adenoma, all of which are suppressed by concomitant loss of p62 or Nrf2 [30] [31] [32] .
In this study, we identify a form of regulation of lipid metabolism through selective autophagy of NCoR1, a negative regulator of the nuclear receptor PPARα. Inactivation of autophagy in mouse livers is accompanied by accumulation of NCoR1 and subsequent inactivation of PPARα, resulting in impaired lipid oxidation and reduced production of ketone bodies under fasting conditions. In mechanistic terms, NCoR1 interacts with gammaaminobutyric acid receptor-associated protein (GABARAP), an autophagosome-localizing protein, in a GABARAP-interacting motif (GIM)-dependent manner, and is degraded by autophagy. Our data provide insights into the physiological role of selective autophagy in metabolic regulation.
Results
Impaired lipid oxidation in autophagy-deficient livers. To investigate the changes in lipid metabolism resulting from the loss of autophagy, we conducted comprehensive lipidome analyses in livers of control (Atg7 f/f ) and mutant mice carrying a hepatocytespecific knockout of Atg7, a gene essential for autophagy (Atg7 f/f ; Alb-Cre mice). In the livers of 5-week-old Atg7 f/f and Atg7 f/f ;Alb-Cre mice, we identified a total of 524 individual lipid species by liquid chromatography-tandem mass spectrometry (LC-MS/MS) ( Supplementary Figure 1 ). Among them, acylcarnitine molecular species differed markedly between the two groups (Supplementary Figure 2 ). Carnitine is a carrier for long-fatty acids, and facilitates their transport into mitochondria for lipid oxidation, which is markedly induced in parallel with autophagy ( Fig. 1a ). Although the levels of most acylcarnitine species in liver were significantly higher in Atg7 f/f ;Alb-Cre mice than in Atg7 f/f mice at 5 weeks of age, under both fed and fasting conditions ( Fig. 1b ), the amount of carnitine was lower under fasting conditions ( Fig. 1c ). Similar alterations were also observed in livers of Atg5 f/f ; Mx1-Cre mice 1 to 2 weeks after intraperitoneal injection of polyinosinic-polycytidylic acid (pIpC), which induced liverspecific deletion of Atg5, another gene essential for autophagy ( Fig. 1b and c). We did not observe any morphological abnormal mitochondria in hepatocytes of both 5-week-old Atg7 f/f ;Alb-Cre mice and of Atg5 f/f ;Mx1-Cre mice at 1 to 2 weeks after injection of pIpC ( Supplementary Figure 3) . Considering that the failure of mitochondrial β-oxidation increases the ratio of acylcarnitine/ carnitine 33 , these results suggest that lipid metabolism is impaired by loss of autophagy at the step of β-oxidation, rather than at the step of fatty-acid supply. Indeed, while blood glucose and free fatty-acid levels in Atg7 f/f ;Alb-Cre and pIpC-injected Atg5 f/f ;Mx1-Cre mice were comparable with those in control mice ( Fig. 1d, e ), the blood level of β-hydroxybutyrate (β-OHB), one of the ketone bodies, was significantly lower in both mutant mice than in control mice under fasting conditions ( Fig. 1f ), suggesting that lipid oxidation was suppressed in the livers of both types of mutant mice. In fact, we observed lower levels of β-OHB in the liver in pIpC-injected Atg5 f/f ;Mx1-Cre mice than in control mice, regardless of nutrient conditions ( Fig. 1g , left graph). An in vivo tracer study using [ 13 C]-palmitate revealed that fasting produces 13 C-β-OHB, but the amount in mutant livers was much lower ( Fig. 1g , right graph). These results suggest that β-oxidation is impaired in autophagy-deficient livers, resulting in lower production of ketone bodies under fasting conditions. a b Acylcarnitine (fast) Relative to Ctrl Acylcarnitine (fed) 
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Decreased PPARα protein in autophagy-deficient livers. We speculated that reduced expression of genes encoding enzymes related to lipid oxidation in autophagy-deficient mouse livers was causing these changes. Indeed, the expression level of such genes was markedly suppressed in livers of both Atg7 f/f ;Alb-Cre ( Fig. 2a ) and pIpC-injected Atg5 f/f ;Mx1-Cre mice, even under fed conditions ( Supplementary Figure 4a ). Fasting increased the transcript levels of β-oxidation-related genes such as Carnitine O-palmitoyltransferase 1, liver isoform (Cpt1a), Carnitine O-palmitoyltransferase 2, mitochondrial (Cpt2), and carnitineacylcarnitine translocase (Cact) in both control and mutant livers, but the level of induction was significantly lower in mutant livers than in controls ( Fig. 2a and Supplementary Figure 4a ). In the next series of experiments, we investigated the levels of the nuclear receptor PPARα, a master regulator of lipid metabolism, and its co-repressor NCoR1. Remarkably, PPARα protein was barely detectable in nuclear fractions of livers of Atg7 f/f ;Alb-Cre mice, regardless of nutrient conditions (Fig. 2b) . The level of PPARα mRNA was lower in mutant livers than in control livers ( Fig. 2b) , consistent with the idea that PPARα regulates its own expression. In marked contrast to the reduction in PPARα, we observed prominent accumulation of NCoR1 in both nuclear and cytoplasmic fractions of livers of Atg7 f/f ;Alb-Cre mice, not accompanied by upregulation of NCoR1 gene expression ( Fig. 2a, b ). Fasting decreased NCoR1 in both fractions of mutant livers, but the levels were still higher than those in control livers ( Fig. 2b ). In our experimental setting, we did not detect NCoR1 in both cytosolic and nuclear fractions of liver homogenates of Atg7 f/f mice (Fig. 2b ). But, NCoR1 was clearly recognized in both nuclear and cytoplasmic fractions of primary hepatocytes isolated from Atg7 f/f mice, and they decreased upon ketogenic conditions ( Fig. 2c ). Similar to in vivo analysis, the deletion of Atg7 by expression of Cre-recombinase was accompanied by the accumulation of NCoR1 (Fig. 2c ). Expression of PPARα target genes was inversely correlated to NCoR1 level ( Fig. 2d ). In agreement with the biochemical data, immunohistofluorescence analysis revealed higher signal intensities of nuclear NCoR1 in Atg7-deficient hepatocytes than in control hepatocytes under both fed and fasting conditions ( Fig. 2e ).
Suppression of β-oxidation dependent on NCoR1. To examine the regulation of PPARα through autophagy in more detail, we deleted ATG7 in the human hepatocyte carcinoma cell line HepG2, using CRISPR/Cas9 technology. Consistent with previous reports 4, 34 , conversion of LC3-I to LC3-II was impaired in the knockout cells ( Fig. 3a ). p62 markedly accumulated in the mutant cells ( Fig. 3a) , and expression of Nrf2-target genes such as NAD (P)H quinone dehydrogenase 1 (NQO1), glutamate-cysteine ligase catalytic subunit (GCLC), and UDP-glucose 6-dehydrogenase (UGDH) was significantly induced (Fig. 3b ). Not surprisingly, loss of ATG7 caused the accumulation of NCoR1 in both cytosolic and nuclear fractions of HepG2 cells ( Fig. 3a) , resulting in suppression of gene expression of PPARα target genes ( Fig. 3b ). Chromatin immunoprecipitation (ChIP) with an antibody against acetylated lysine 27 of histone H3 (H3K27ac), which is an enhancer mark, coupled with quantitative PCR showed that deposition of H3K27ac in the promoter regions of PPARα target genes such as CPT1A and CPT2 was significantly diminished in the absence of ATG7 (Fig. 3c ). Such decrease was not obvious in the case of the promoter of an Nrf2-target, NQO1 (Fig. 3c ). GATA1 exon 3 was examined as a negative control locus. These results suggest that the increase of NCoR1 recruitment to the regulatory regions of PPARα target genes in ATG7-deficient cells suppresses the enhancer formation, which is consistent with the function of NCoR1 as a co-repressor.
Knockdown of p62 in ATG7-deficient HepG2 cells suppressed expression of Nrf2-target genes, but had no effect on the repression of PPARα target genes ( Fig. 4a, b ). Conversely, suppression of PPARα target genes in ATG7 −/− HepG2 cells was abolished by simultaneous knockdown of NCoR1 ( Fig. 4c, d ). In accordance with a previous study of liver-specific NCoR1knockout mice 35 , loss of NCoR1 in HepG2 cells led to prominent induction of PPARα target genes ( Fig. 4e , f). In both wild-type and NCoR1-knockout HepG2 cells, expression of PPARα target genes was repressed by overexpression of NCoR1 (Fig. 4e, f) . These results suggest that quantitative control of NCoR1 has an impact on expression of PPARα target genes.
In the next series of experiments, we examined the effect of accumulation of p62 and/or NCoR1 in autophagy-incompetent mouse livers. As previously reported 36 , severe hepatomegaly and liver injury observed in hepatocyte-specific Atg7-knockout mice were ameliorated by concomitant loss of p62 ( Supplementary  Figure 5a and b, upper graphs), and induced expression of Nrf2target genes in Atg7 f/f ;Alb-Cre mouse livers was robustly downregulated ( Supplementary Figure 5c , upper graphs). On the other hand, reduced expression of PPARα target genes was still observed in livers of Atg7 f/f ;p62 f/f ;Alb-Cre mice, in which both Atg7 and p62 were deleted in hepatocytes, regardless of nutrient conditions ( Fig. 5a ). We confirmed the significant reduction of nuclear PPARα levels, as well as the marked accumulation of both nuclear and cytoplasmic NCoR1, in livers of Atg7 f/f ;p62 f/f ;Alb-Cre mice ( Fig. 5b ). Such sharp fluctuations were detected even in fasting conditions ( Fig. 5b) . Likewise, the decreased expression of PPARα-targets in the Atg5 −/− livers was not ameliorated by the additional deletion of p62 ( Supplementary Figure 4b ). Next, we crossbred Atg7 f/f ;Alb-Cre with NCoR1 f/f mice 37 to generate hepatocyte-specific Atg7/NCoR1 double-knockout mice. Concomitant loss of NCoR1 in Atg7-knockout mouse livers abolished the suppression of PPARα target genes, albeit not completely (Supplementary Figure 6a ). As with liver-specific Atg7-single knockout mice, Atg7 f/f ;NCoR1 f/f ;Alb-Cre mice exhibited severe liver enlargement and injury ( Supplementary Figure 5a and b, bottom graphs), raising the possibility that this pathological condition influences expression of PPARα target genes. To exclude this possibility, we generated Atg7 f/f ;p62 f/f ;NCoR1 f/f ;Alb-Cre mice. Liver phenotypes in Atg7 f/f ;NCoR1 f/f ;Alb-Cre mice were substantially ameliorated by simultaneous ablation of p62: both hepatomegaly and leakage of hepatic enzymes into sera, observed in Atg7 f/f ;NCoR1 f/f ;Alb-Cre mice, were largely abrogated by additional loss of p62 ( Supplementary Figure 5a and b, bottom graphs). Loss of p62 also decreased the induction of Nrf2-target genes in livers of Atg7 f/f ;NCoR1 f/f ;Alb-Cre mice ( Supplementary  Figure 5c , bottom graphs). Remarkably, the suppression of PPARα target genes in Atg7 −/− p62 −/− double-knockout livers was alleviated by additional loss of NCoR1 (Fig. 5c ). In stark contrast to the significant accumulation of NCoR1 in both the nuclear and cytoplasmic fractions of Atg7 p62 double-knockout livers (Fig. 5b) , the signal was abolished by additional loss of NCoR1 ( Fig. 5d ). Consequently, the reduction in the nuclear level of PPARα in Atg7 p62 double-knockout livers was rescued by simultaneous loss of NCoR1 (Fig. 5d ). Immunohistofluorescence microscopy confirmed that the signal intensity of nuclear NCoR1 was higher in Atg7 −/− p62 −/− hepatocytes than in control hepatocytes ( Fig. 5e ). As expected, no nuclear signals were recognized in Atg7 p62 NCoR1 triple-knockout hepatocytes, which validated the signals observed in other genotypes ( Fig. 5e ). Further, the blood level of β-OHB in Atg7 f/f ;p62 f/f ;Alb-Cre mice was still lower than in control mice under fasting conditions, which was restored by additional loss of NCoR1 (Fig. 5f ). Although the expression of PPARα target genes was not influenced by single deletion of p62, it was significantly induced 
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Relative mRNA NCoR1 is a substrate for autophagy. How does autophagy affect the level of NCoR1? First, we examined the kinetics of NCoR1 in response to starvation under autophagy-intact or -defective conditions. Amino-acid starvation caused a marked decrease in NCoR1 levels in both nuclear and cytoplasmic fractions of control siRNA-treated HepG2 cells (Fig. 6a ). This reduction was largely inhibited by knockdown of ATG7 (Fig. 6a ). The treatment of wild-type HepG2 cells with the lysosomal protease inhibitors E64d and pepstatin A caused a marked increase in the NCoR1 level (Fig. 6b ). The amounts of both nuclear and cytoplasmic NCoR1 in ATG7 −/− HepG2 cells decreased upon expression of wild-type ATG7, but not expression of GFP or an active-site mutant of ATG7, ATG7 C572S (Fig. 6c ). Starvation promoted the ATG7-mediated decrease in the NCoR1 level ( Fig. 6c ). Oxygen consumption rate (OCR) in ATG7-deficient HepG2 cells under βoxidation conditions tended to be lower than in cells expressing wild-type ATG7. Moreover, the addition of etomoxir, which binds irreversibly to the CPT1A transporter and inhibits fattyacid oxidation, barely had an effect on the OCR (Fig. 6d ). In marked contrast, the OCR in ATG7 −/− HepG2 cells expressing ATG7 significantly decreased in response to treatment with etomoxir ( Fig. 6d ).
Immunofluorescence staining revealed that endogenous NCoR1 and an autophagosome-localizing protein, GABARAP (gamma-aminobutyric acid receptor-associated protein), colocalized in cytoplasmic puncta structures of HepG2 cells ( Fig. 7a ), although we could not investigate the co-localization of NCoR1 with LC3 due to the lack of a monoclonal antibody for LC3. Most (55.4 ± 2.98%) of cytoplasmic NCoR1 punctae were positive for GABARAP. Consistent with the biochemical results ( Fig. 6a ), amino-acid starvation for 12 h decreased the number of such structures, probably due to autophagic degradation (Fig. 7a ). The treatment of HepG2 with bafilomycin A 1 , an inhibitor of vacuolar H + -ATPases, increased the structures positive for both GABARAP and NCoR1 ( Supplementary Figure 7) . We also carried out immunofluorescent analysis with anti-LAMP1 and anti-NCoR1 antibodies. As expected, both proteins were colocalized in wild-type but not Atg7-deficient HepG2 cells (Fig. 7b ). In ATG7-knockout HepG2 cells, NCoR1 formed small punctate structures in both nucleus and cytoplasm, in addition to the large cytoplasmic puncta (Fig. 7a ). Among these structures, GABARAP mainly co-localized to large cytosolic NCoR1-positive structures, regardless of nutrient conditions (Fig. 7a ). Unlike wild-type HepG2 cells, the abundance of these structures did not decrease upon starvation (Fig. 7a ). Our previous genetic studies showed the formation of LC3-dots through the interaction of LC3 with p62 even in Atg7-deficient mouse hepatocytes 4, 36 . Likewise, excessive accumulation of NCoR1 might sequester GABARAP due to their physical interaction, irrespective of the lipidation of GABARAP. Next, to investigate whether NCoR1 interacts with LC3 and/or GABARAP, we expressed One-Strep-FLAG-tagged LC3B or GABARAP family proteins (GABARAP, gamma-aminobutyric acid receptor-associated protein-like [GABARAPL]1 and GABARAPL2) and performed pull-down assays. HEK293T cells were utilized for the pull-down assays due to their high transfection efficiency and protein production. In agreement with previous reports 38 , these assays confirmed the specific binding of ULK1 to GABARAP family proteins, as well as binding of p62 to both LC3B and GABARAP family proteins ( Fig. 8a) , indicating that our experimental setting works as expected. Similar to ULK1, NCoR1 bound to GABARAP family proteins, but not LC3B (Fig. 8a) . To determine which domain of NCoR1 is required for its interaction with GABARAP family proteins, we constructed a series of NCoR1-deletion mutants (Fig. 8b, left panel) and performed pull-down assays with the One-Strep-FLAG-tagged GABARAP. NCoR1 N (aa 1-674) and NCoR1 ΔC (aa 1-1149) were clearly detected in the precipitant (Fig. 8b, middle panel) . However, deletion mutants NCoR1 M (aa 675-1500), NCoR1 C (aa 1501-2440), and NCoR1 ΔN (1150-2440) exhibited a marked decrease in binding to GABARAP (Fig. 8b, middle panel) . To narrow down the interaction domain, we prepared a series of deletions starting from NCoR1 ΔC (N1-N4) (Fig. 8b, left panel) and performed pull-down assays. These assays revealed that NCoR1 N1, covering amino acids 1-370, is sufficient for the interaction between NCoR1 and GABARAP (Fig. 8b, right panel) . We noticed that a region within NCoR1 N1 (aa 344-349) contained a potential LC3-interacting region (LIR) 27 /GABARAP-interacting motif (GIM) 39 , KQFPEI, which is conserved in species as divergent as C. elegans (Fig. 8c ). Deletion of the FPEI sequence (NCoR1 ΔLIR/ GIM) limited the ability of NCoR1 to bind GABARAP, as judged by pull-down assay (Fig. 8d) .
To investigate whether NCoR1 is degraded by autophagy in a LIR/GIM-dependent manner, we expressed FLAG-tagged wildtype and ΔLIR/GIM NCoR1 in NCoR1-deficient HepG2 cells. Both wild-type and mutant were efficiently expressed in the cells (Fig. 9a ). Similar to the dynamics of endogenous NCoR1 (Fig. 6a) , exogenous wild-type NCoR1 decreased in response to amino-acid starvation, which was not the case for NCoR1 ΔLIR/GIM (Fig. 9a ). Consistent with this biochemical data, immunofluorescence analysis showed that FLAG-NCoR1 but not NCoR1 - ARTICLE ΔLIR/GIM was delivered to lysosome (Fig. 9b ). Furthermore, GIM-deleted NCoR1 has a higher suppressive effect on the expression of PPARα target genes than wild-type NCoR1 under amino-acid starvation conditions (Fig. 9c ). Taken together, these results strongly suggest that NCoR1 is selectively degraded by autophagy in a LIR/GIM-dependent manner and that it is indispensable for transactivation of PPARα in response to starvation.
Discussion
NCoR1 serves as scaffold that facilitates interaction of several docking proteins to fine-tune transactivation of transcription factors, in particular nuclear receptors that have important roles in metabolic control. Interaction of NCoR1 with nuclear receptors and histone deacetylases is vital for nuclear receptor-mediated downregulation of gene expression 40 in response to ligands/agonists, this repression is modulated at multiple levels, including gene expression, post-translational modifications such as ubiquitination and phosphorylation, and proteasomal degradation of NCoR1 41 . In this study, we found that autophagy also participates in regulation of the activity of the nuclear receptor PPARα through degradation of NCoR1, and that suppression of liver autophagy is accompanied by defective β-oxidation and ketogenesis. Under nutrient-rich conditions, mechanistic target of rapamycin complex 1 (mTORC1) phosphorylates ribosomal protein S6 kinase 2 (S6K2). NCoR1 forms a complex with the S6K2, and the resultant complex translocates into the nucleus to suppress genes encoding enzymes involved in β-oxidation 42 . mTORC1 also binds and phosphorylates TFEB, a master transcription factor for a battery of Atg and lysosomal genes, causing it to be retained in the cytoplasm [43] [44] [45] . In response to nutrient deprivation and subsequent mTORC1 inactivation, nuclear translocation of NCoR1 is inhibited, TFEB is concomitantly dephosphorylated, and ULK1 kinase, an upstream factor involved in autophagosome formation, is activated. Consequently, both autophagy and β-oxidation followed by production of ketone body occur at the same time 46 . At this time, the autophagic degradation of NCoR1 contributes to PPARαactivation to effectively promote β-oxidation in response to physiological fasting (Fig. 9d ). Previously, autophagy was thought to contribute to lipid oxidation by increasing the supply of free fatty acids (lipophagy). However, here we propose that autophagy is integrated into a highly sophisticated regulatory mechanism for a nuclear factor, PPARα, and that for this reason, impairment of autophagy in the liver causes defects in β-oxidation and ketogenesis. We observe a marked reduction in PPARα in autophagydeficient mouse livers. However, the phenotypes of liver-specific Atg7-knockout mice are likely to be different from those of liverspecific PPARα-knockout mice, which have higher levels of liver triglyceride and cholesterol ester during fasting and exhibit severe steatosis 47 . In fact, we recognized a slight increase in the levels of some molecular species of triglyceride and cholesterol esters in Atg7-deficient mouse livers ( Supplementary Figure 1) . Repression of the transactivation of nuclear receptors by NCoR1 in livers is not restricted to PPARα. For example, NCoR1 modulates transactivation of nuclear receptors such as LXRα and estrogen-related receptor α (ERRα) other than PPARα 41 . Thus, suppression of liver autophagy should be accompanied by repression of multiple nuclear receptors. Indeed, LXRα target genes that encode enzymes involved in lipogenesis are downregulated in mouse livers lacking Rb1cc1 (also called Fip200), a component of the ULK1 kinase complex 21 . Consistent with this, our microarray analysis of Atg7 −/− mouse livers (GEO accession number: GSE65174) 48 revealed a reduced expression of LXRα and PPARα target genes. We verified the NCoR1-dependent suppression of LXRα-targets ( Supplementary Figure 8a-d) and of LXRα protein ( Supplementary Figure 8e-h) in autophagy-deficient livers. Given the concurrent suppression of genes related to both lipogenesis and lipid oxidation upon loss of Atg7, lipid metabolism in the mutant livers is apparently stable under normal conditions, but should be stagnant under conditions in which fatty acids are mobilized. Indeed, liver steatosis under physiological fasting and high-fat diet conditions was abolished by loss of Rb1cc1, Atg7, or Atg5 [19] [20] [21] 23 . We also verified the impairment of physiological hepatosteatosis upon fasting in Atg7 f/f ;Alb-Cre mice (Supplementary Figure 9 ). In sharp contrast, loss of NCoR1 in mouse livers causes induction of gene sets regulated by LXRα, PPARα, and ERRα, leading to concurrent induction of lipogenesis and lipid oxidation 35 . In Atg7 p62 NCoR1 triple-knockout livers, the expression of PPARα target genes recovered up to control levels (Fig. 5a) . In contrast to NCoR1-knockout livers, however, we did not observe higher induction of the targets ( Supplementary Figure 4) , implying the presence of a still-hidden suppressive mechanism.
Recently, Sinha et al. 49 reported that phosphorylation of RPS6KB1 induced by knockdown of ULK1 promotes nuclear translocation of NCoR1. We examined the phosphorylation level of RPS6KB1 in Atg7-deficient hepatocytes and found that the level was comparable to that in control cells ( Supplementary  Figure 10) , implying that the nuclear accumulation of NCoR1 in Atg7-knockout livers depends on a distinct mechanism from the RPS6KB1-mediated translocation of NCoR1. In addition, Sinha et al. showed that the nuclear accumulation of NCoR1 downregulates the expression of the SCD1 gene encoding stearoyl-CoA desaturase, which converts saturated fatty acids (SFAs) to monounsaturated fatty acids (MUFAs). As a result, it increases the ration of SFAs/MUFAs and then suppresses lipid droplet formation 49 . SCD1 is a target of LXRα, and the ration of SFAs/ MUFAs in Atg7-deficient mouse livers (1.55 ± 0.21/25.2 ± 3.28, ± s.e.m., n = 3) was higher than that in control mouse livers (1.12 ± 0.37/30.23 ± 6.88, ± s.e.m., n = 3). Thus, the increased saturated fatty acids may also affect physiological hepatosteatosis in response to fasting in Atg7 f/f ;Alb-Cre mice.
In general, selective substrates for autophagy are tagged with a molecular marker that includes ubiquitin, leading to assembly of receptor proteins that bind to both marker molecules and the ATG8 family proteins (including LC3A, LC3B, LC3C, GABARAP, GABARAPL1, and GABARAPL2) near the cargos 50, 51 . Most receptor proteins have LIR/GIM domains that mediate their interactions with ATG8 family proteins 27, 39 . Ubiquitin-chain and/or receptor proteins on the cargos recruit core autophagy proteins such as FIP200, ULK1, and WIPI1 52, 53 , beginning the process of autophagosome formation around the targets. Thus, cargo labeling and the transfer of receptor proteins to cargos mainly regulate selective autophagy. In the case of selective autophagy for NCoR1, ubiquitination may serve as a signaling tag. NCoR1 is ubiquitinated by the ubiquitin ligase TBLR1 and subsequently degraded by the proteasome 54, 55 . Because NCoR1 translocates from the nucleus to cytoplasm in response to nutrient starvation, ubiquitination of NCoR1 may be a signal not only for proteasomal degradation but also for selective autophagy, both of which favor the exchange of corepressors for co-activators. Because fasting decreased the levels of both nuclear and cytoplasmic NCoR1 even in Atg7-knockout livers (Fig. 2b) , the ubiquitin-proteasome pathway may contribute to the degradation of NCoR1. Notably, although NCoR1 is a selective substrate for autophagy, like receptor proteins for selective autophagy, it has a LIR/GIM and directly interacts with GABARAP family (Fig. 8) . Therefore, NCoR1 is a hybrid protein with characteristics of both autophagy substrates and receptors; accordingly, receptor protein(s) might be dispensable for this type of selective autophagy.
Because both NCoR1 and GABARAP family are ubiquitously expressed, it is plausible that selective autophagy of NCoR1 Subsequently, both nuclear and cytoplasmic fractions were prepared from the HepG2 cells and subjected to immunoblotting with the indicated antibodies. Data are representative of three separate experiments. Bar graphs indicate the quantitative densitometric analyses of cytoplasmic and nuclear NCoR1 relative to Gapdh and Lamin B, respectively. c Immunoblot analysis. GFP, wild-type ATG7, or ATG7 C572S was expressed in ATG7-knockout HepG2 (#14) cells by adenovirus system. Forty-eight hours after infection, the cells were cultured under nutrient-rich or -deprived conditions. Thereafter, both nuclear and cytoplasmic fractions were prepared and subjected to immunoblotting with the indicated antibodies. Data shown are representative of three separate experiments. Bar graphs indicate the quantitative densitometric analyses of cytoplasmic and nuclear NCoR1 relative to Gapdh and Lamin B, respectively. d Oxygen consumption rate (OCR). OCR of ATG7 −/− HepG2 cells (#14) expressing GFP or wild-type ATG7 in β-oxidation assay medium was measured using a Seahorse XF24 Extracellular Flux Analyzer. Etomoxir (final concentration 40 μM) was added to the cells after baseline measurement in assay medium. Arrows indicate the time when etomoxir was added to the cells. The graphs represent the average OCR at four time points. Data are means ± s.e.m. *P < 0.05, **P < 0.01, and ***P < 0.001 as determined by Welch's t-test occurs in most tissues. However, the corresponding nuclear receptors for NCoR1 differ according to tissue type, implying that accumulation of NCoR1 due to loss of autophagy has distinct effects among tissues. Suppression of autophagy in metabolic tissues is associated with degeneration and defective differentiation 56 . Although the former is thought to be due to impairment of cellular homeostasis and to p62-mediated Nrf2 activation (in the case of liver), the reason for the latter remains unclear. Recent work with tissue-specific NCoR1-knockout mice revealed that loss of NCoR1 results in the activation of distinct transcription factors in specific tissues. For example, expression of PPARγ target genes is specifically induced in adipocyte-specific NCoR1-knockout mice, which exhibit increased insulin sensitivity in liver, fat, and muscle, and develop obesity and expansion of fat tissue on a highfat diet due to an increase in the number of small adipocytes and reduced inflammation in adipose tissue 57 . In muscle-specific NCoR1-deficient mice, PPARβ/δ, ERRs, and myocyte-specific enhancer factor 2 (MEF2) are selectively activated, and the mutant mice exhibit increased mitochondrial size and number, increased endurance with more muscle mass and oxidative fibers, and induction of oxidative metabolism 37 . By contrast, adipogenesis is impaired in adipocyte-specific Atg7 or Atg5-knockout mice, leading to a lean phenotype 58, 59 . Loss of Atg5 or Atg7 in mouse skeletal muscle causes muscle atrophy and weakness, as well as accumulation of degenerated mitochondria 60, 61 . These phenotypes could be explained by the accumulation of NCoR1 and subsequent deregulation of transcription networks, in addition to defective cellular homeostasis.
Methods
Cell culture. HepG2 (ATCC HB-8065) and HEK293T (ATCC CRL-3216) cells were grown in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum (FBS), 5 U/mL penicillin, and 50 μg/mL streptomycin. To generate ATG7-knockout or NCoR1-knockout HepG2 cells, ATG7 or NCoR1 guide RNA designed using the CRISPR Design tool (http://crispr.mit.edu/) was subcloned into pX330-U6-Chimeric_BB-CBh-hSpCas9 (Addgene #42230), a human codonoptimized SpCas9 and chimeric guide RNA expression plasmid. HepG2 cells were co-transfected with vectors pX330 and pEGFP-C1 (#6084-1, Clontech Laboratories, Mountain View, CA, USA), and cultured for 2 days. Thereafter, GFPpositive cells were sorted and expanded. Loss of ATG7 or NCoR1 was confirmed by heteroduplex mobility assay followed by immunoblot analysis with anti-ATG7 or anti-NCoR1 antibody. For knockdown experiments, HepG2 cells were transfected with 25 nM SMARTpool siRNA for ATG7, p62, or NCoR1 using Dharmafect 1 (Thermo Fisher Scientific, Waltham, MA, USA). NCoR1 was expressed using a helper-dependent adenovirus vector system 62 containing loxP at position 143 63 . To exogenously express GFP, ATG7, or ATG7 C572S , we used the Adenovirus Expression Vector Kit (Takara Bio, Kusatsu, Japan). Cells were plated onto 6-well ARTICLE dishes in 2 mL of growth medium 24 h before infection. The medium was replaced with fresh medium containing adenovirus with a multiplicity of infection (MOI) of 50. Cells were lysed 48 h later, and lysates were analyzed by immunoblotting. To inhibit degradation in lysosomes, HepG2 cells were treated with E64d (10 μg/mL) and pepstatin A (10 μg/mL), and HepG2 cells were treated with Bafilomycin A 1 (0.01 μM final, Wako, 023-11641). E64d and Pepstatin A were from Peptide Institute (Osaka, Japan).
Measurement of cellular oxygen consumption rate. HepG2 cells were spread onto 10-cm dishes and cultured in DMEM containing 10% FBS. Twelve hours after plating, the medium was replaced with fresh medium containing adenovirus vector. After 24 h, infected HepG2 cells were seeded on XF24 cell culture plates (50,000 cells per well) and cultured in 500 μL DMEM containing 10% FBS overnight. The culture medium was removed from each well and replaced with 375 μL fatty-acid oxidation (FAO) medium consisting of 111 mM NaCl, 4.7 mM KCl, 1.25 mM
Total
Pull-down OSF-GABARAP and FLAG-NCoR1 or NCoR1 ΔLIR/GIM were co-expressed in HEK293T cells. The assay was carried out as described in a CaCl 2 , 2 mM MgSO 4 , 1.2 mM Na 2 HPO 4 , 2.5 mM glucose, 0.5 mM carnitine, and 5 mM HEPES. Cells were incubated in a CO 2 -free incubator at 37°C for 45 min. An XF Instrument (Agilent Technologies, Santa Clara, CA, USA) gently mixed the assay media in each well for 10 min to allow the oxygen partial pressure to reach equilibrium. The oxygen consumption rate (OCR) was measured simultaneously three times to establish a baseline rate. For each measurement, with a total of 16 measurements, there was a 3-min mix followed by a 3-min wait time to restore normal oxygen tension and pH in the microenvironment surrounding the cells. Drug injection was performed throughout the assay. Etomoxir (40 μM final, Wako, E933505) was injected after measurements 4 and 8. Fig. 9 Autophagic degradation of NCoR1 dependent on the GABARAP-interaction. Immunoblot analysis. FLAG-NCoR1 or NCoR1 ΔLIR/GIM was expressed in NCoR1-knockout HepG2 cells. Forty-eight hours after transfection, the cells were cultured in nutrient-rich medium, or nutrient-deprived medium. Thereafter, cytoplasmic and nuclear fractions were prepared and subjected to immunoblotting with the indicated antibodies. Data are representative of three independent experiments. Bar graphs indicate the quantitative densitometric analyses of cytoplasmic and nuclear FLAG-NCoR1 and FLAG-NCoR1 ΔLIR/GIM relative to Gapdh and Lamin B, respectively. b Immunofluorescence analysis. FLAG-NCoR1 or NCoR1 ΔLIR/GIM was expressed in NCoR1deficient HepG2 cells. Forty-eight hours after transfection, the cells were cultured in nutrient-rich medium, or nutrient-deprived medium for 6 h and then immunostained with anti-NCoR1 antibody. To label lysosomes, the cells were incubated with Lyso Tracker Deep Red (50 nM final) for 2 h before the immunostaining. c Real-time PCR analysis. Total RNAs were prepared from cells described in a. Values were normalized against the amount of mRNA in NCoR1-deficient HepG2 cells expressing FLAG. The experiments were performed three times. d Model of PPARα transactivation through selective autophagic degradation of NCoR1. Data are means ± s.e.m. *P < 0.05, **P < 0.01, and ***P < 0.001 as determined by Welch's t-test Lipidome analysis. Lipidome analysis was performed as described previously with slight modification 66 . Tissues (15-45 mg) were crushed to powder with an SK mill (SK-100; Tokken, Chiba, Japan) without thawing, and lipids were extracted by the method of Bligh and Dyer 67 with internal standards. The organic (lower) phase was transferred to a clean vial and dried under a stream of nitrogen. The lipids were then resolubilized in methanol containing 0.1% (v/v) formic acid, and a portion of the extracted lipid was injected onto the liquid chromatography/tandem mass spectrometry (LC-MS/MS) system. LC separation was performed on an ACQUITY UPLC™ BEH C 18 A portion of the liver lobule was sampled for snap-freezing using liquid nitrogen. Collected liver tissues were stored −80°C until use. Metabolite extraction from tissues for metabolome analyses was performed as described previously 68 . Frozen livers together with internal standard (IS) compounds (2-morpholinoethanesulfonic acid (MES) and 1,3,5-benzenetricarboxylic acid (trimesate)) was homogenized in ice-cold methanol (500 μL) using a manual homogenizer (Finger Masher (AM79330), Sarstedt), followed by the addition of an equal volume of chloroform and 0.4 volumes of ultrapure water (LC/MS grade, Wako). The suspension was then centrifuged at 15,000 × g for 15 min at 4°C. After centrifugation, the aqueous phase was ultrafiltered using an Ultrafree MC-PLHCC ultrafiltration tube (Human Metabolome Technologies). The filtrate was concentrated on a vacuum concentrator (SpeedVac, Thermo). The concentrated filtrate was dissolved in 50 μL of ultrapure water and subjected to IC-MS analyses. For metabolome analysis focused on ketone body production from administered 13 C 16 -palmitate, anionic metabolites were measured using an Orbitrap-type MS (Q-Exactive focus, Thermo Fisher Scientific) connected to an high performance ion-chromatography system (ICS-5000+, Thermo Fisher Scientific) that enabled us to perform highly selective and sensitive metabolite quantification owing to the IC-separation and Fourier Transfer MS principle 69 . The IC was equipped with an anion electrolytic suppressor (Thermo Scientific Dionex AERS 500), which converted the potassium hydroxide gradient into pure water before the sample entered the mass spectrometer. Separation was performed using a Thermo Scientific Dionex IonPac AS11-HC, 4-μm particle size column. The IC flow rate was 0.25 mL/min supplemented post-column with 0.18 mL/min makeup flow of MeOH. The potassium hydroxide gradient conditions for IC separation are as follows: from 1 mM to 100 mM (0-40 min), 100 mM (40-50 min), and 1 mM (50.1-60 min), at a column temperature of 30°C. The Q-Exactive focus mass spectrometer was operated under ESI-negative mode for all detections. Full mass scan (m/z 70-900) was used at a resolution of 70,000. The automatic gain control target was set at 3 × 10 6 ions, and maximum ion injection time was 100 ms. Source ionization parameters were optimized with the spray voltage at 3 kV, and other parameters were as follows: transfer temperature at 320°C, S-Lens level at 50, heater temperature at 300°C, Sheath gas at 36, and Aux gas at 10.
Statistical analysis. Values, including those displayed in the graphs, are means ± s.e.m. Statistical analysis was performed using the unpaired t-test (Welch test) (two-sided). A P-value <0.05 was considered to indicate statistical significance.
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